''Clinical and Vaccine Immunology'' (''CVI'') was a

peer-reviewed Peer review is the evaluation of work by one or more people with similar competencies as the producers of the work ( peers). It functions as a form of self-regulation by qualified members of a profession within the relevant field. Peer revie ...

journal published by the

American Society for Microbiology The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It w ...

. ''CVI'' enhances our understanding of the immune response in health and disease by showcasing important clinically relevant research, including new animal models for human immunologic diseases, viral immunology, immunopathogenesis, and clinical laboratory immunology. In particular, the journal highlights important discoveries in immunization and vaccine research, such as the development and evaluation of vaccines, human and animal immune responses to vaccines, vaccine vectors, adjuvants and immunomodulators, quantitative assays of vaccine efficacy, and

clinical trials Clinical trials are prospective biomedical or behavioral research studies on human participants designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietar ...

. The journal publishes primary research articles, editorials, commentaries, minireviews, and case reports. Articles are freely accessible after six months (

delayed open access Delayed open-access journals are traditional subscription-based journals that provide free online access upon the expiry of an embargo period following the initial publication date. Details The embargo period before an article is made available ...

). Through its "Global Outreach Program", free online access is available to qualified microbiologists in eligible developing countries.

History

''Clinical and Vaccine Immunology'' (''CVI'') was originally launched in 1994 as ''Clinical and Diagnostic Laboratory Immunology''. Dr. Steven D. Douglas was the Founding Editor and served as Editor in Chief until 2004. The focus and intent of the journal was to serve the new ASM Division V, Clinical and Diagnostic Immunology. Douglas was succeeded by Dr. Susan F. Plaeger, ''CVI'''s Editor in Chief until 2013. Under Plaeger's leadership, and in response to ASM members' feedback, the journal expanded its scope to include the growing field of veterinary and human vaccines. In 2006, the ASM Publications Board approved the new name ''Clinical and Vaccine Immunology'', to reflect the inclusion of vaccine research as well as clinical immunology. The reorganization allowed ''CVI'' to attract high-quality research papers in the areas of clinical immunology and vaccinology while maintaining its interest in laboratory immunology and diagnostics. Since then, the journal has enjoyed a sustained increase in citations and impact factor. Areas of interest for ''CVI'' include microbial immunology, clinical immunology and immune mechanisms (in health and disease), veterinary immunology, and all aspects of vaccine research: development and evaluation, adjuvants, immune modulators and antigen-delivery systems, vaccine implementation, and clinical trials. The journal serves ASM members and the broad research community with the high scientific and editorial standards of the ASM Journals and the society itself. It has been named a Rising Star among journals in the field of Immunology in Essential Science Indicators from Thomson Reuters for several months during 2010 and 2011. ''CVI'''s impact factor has increased steadily for the last five years.

Editors in Chief

The following individuals have been editor in chief of ''Clinical and Vaccine Immunology'': * 1994–2003: Steven D. Douglas * 2004–June 2013: Susan F. Plaeger * July 2013 – present: Marcela F. Pasetti

Abstracting and indexing

The journal is abstracted and indexed in: According to the ''

Journal Citation Reports ''Journal Citation Reports'' (''JCR'') is an annual publicationby Clarivate Analytics (previously the intellectual property of Thomson Reuters). It has been integrated with the Web of Science and is accessed from the Web of Science-Core Colle ...

'', the journal has a 2012

impact factor The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as ...

of 2.598 and an

Eigenfactor The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from h ...

score of 0.01727.

References

External links

* {{Official website, http://cvi.asm.org/
Instructions to Authors
Vaccinology journals Delayed open access journals Publications established in 1994 English-language journals Monthly journals American Society for Microbiology academic journals